How many insider trades does FilingIQ track for NRXS?

FilingIQ tracks 25 Form 4 insider transactions for NRXS (Neuraxis, INC), covering filings from Aug 10, 2023 onwards. 5 of those were filed in the last 90 days.

Are NRXS insiders net buyers or net sellers?

Across the full Form 4 history for NRXS, 4 transactions (16%) were open-market purchases and 2 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NRXS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NRXS in?

Neuraxis, INC (NRXS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $81.11M.

NRXS insider trading

NYSE American Healthcare

Neuraxis, INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

16% / 8%

Market cap

$81.11M

About Neuraxis, INC

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Company website: neuraxis.com

NRXS insider activity at a glance

FilingIQ has scored 25 insider transactions for NRXS since Aug 10, 2023. The most recent filing in our index is dated Apr 28, 2026.

Across the full history, 4 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NRXS insider trades is 59.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NRXS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading NRXS

Henrichs Timothy Robert

2 trades · score 70.0

Frequently asked

How many insider trades does FilingIQ track for NRXS?: FilingIQ tracks 25 Form 4 insider transactions for NRXS (Neuraxis, INC), covering filings from Aug 10, 2023 onwards. 5 of those were filed in the last 90 days.
Are NRXS insiders net buyers or net sellers?: Across the full Form 4 history for NRXS, 4 transactions (16%) were open-market purchases and 2 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NRXS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NRXS in?: Neuraxis, INC (NRXS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $81.11M.

Methodology & sources

Every NRXS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.